See also stories tagged with Microfluidics
The costliness of drug development and the limitations of studying physiological processes in the lab are two separate scientific issues that may share the same solution.
Scientists at the Ural Federal University (UrFU) have developed a new sensor device for determining cholesterol levels in blood. The system does not use protein compounds such as enzymes. Chemists replaced them with an inorganic ...
The ability to analyze the properties of individual cells is vital to broad areas of life science applications, from diagnosing diseases and developing better therapeutics to characterizing pathogenic bacteria and developing ...
The research team from Hunan University has proposed a facile and industrially applicable method to fabricate an extreme wettability surface on an Al-based superhydrophobic surface by a composite process of electrochemical ...
Scientists at Swansea University developing a platform that would use artificial intelligence to speed up the process of detecting biomarkers in biofluids have shown that the concept could work. It would mean faster test ...
Biomedical engineers and medical researchers at UNSW Sydney have independently made discoveries about embryonic blood stem cell creation that could one day eliminate the need for blood stem cell donors.
A new publication from Opto-Electronic Advances discusses label-free trace detection of bio-molecules by liquid-interface assisted surface-enhanced Raman scattering using a microfluidic chip.
A research team led by Prof. Chen Yan from the Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences, and their collaborators developed a novel digital droplet microfluidic flow cytometry technique, ...
The ability to manipulate droplets plays a vital role in fundamental research and practical applications from chemical reactions to bio-analysis. Light control of droplets enables remote and contactless control with remarkable ...
A team of scientists, led by Xiling Shen, Ph.D., Chief Scientific Officer, and Professor at the Terasaki Institute for Biomedical Innovation (TIBI), has reached new levels in patient model development. They have developed ...
